View : 13 Download: 0
Structure-activity relationships of 2-chloro-N6-substituted- 4′-thioadenosine-5′-uronamides as highly potent and selective agonists at the human A3 adenosine receptor
- Structure-activity relationships of 2-chloro-N6-substituted- 4′-thioadenosine-5′-uronamides as highly potent and selective agonists at the human A3 adenosine receptor
- Jeong L.S.; Lee H.W.; Jacobson K.A.; Kim H.O.; Shin D.H.; Lee J.A.; Gao Z.-G.; Lu C.; Duong H.T.; Gunaga P.; Lee S.K.; Jin D.Z.; Chun M.W.; Moon H.R.
- Ewha Authors
- 정낙신; 이상국
- Issue Date
- Journal Title
- Journal of Medicinal Chemistry
- vol. 49, no. 1, pp. 273 - 281
- SCI; SCIE; SCOPUS
- We have established structure-activity relationships of novel 4′-thionucleoside analogues as the A3 adenosine receptor (AR) agonists. Binding affinity, selectivity toward other AR subtypes, and efficacy in inhibition of adenylate cyclase were studied. From this study, 2-chloro-N 6-methyl-4′-thioadenosine-5′-methyluronamide (36a) emerged as the most potent and selective agonist at the human A3 AR. We have also revealed that, similar to 4′-oxoadenosine analogues, at least one hydrogen on the 5′-uronamide moiety was necessary for high-affinity binding at the human A3 AR, presumably to allow this group to donate a H bond within the binding site. Furthermore, bulky substituents on the 5′-uronamide reduced binding affinity, but in some cases large 5′-uronamide substituents, such as substituted benzyl and 2-phenylethyl groups, maintained moderate affinity with reduced efficacy, leading to A 3 AR partial agonists or antagonists. In several cases for which the corresponding 4′-oxonucleosides have been studied, the 4′-thionucleosides showed higher binding affinity to the A3 AR. © 2006 American Chemical Society.
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.